Document is current
Any future updates will be listed below
-
Authors
Salgado, Teresa M. https://orcid.org/0000-0003-2708-7145
Quinn, Caroline S.
Krumbach, Emily K.
Wenceslao, Iris
Gonzalez, Martha
Reed, Holly L.
Syverson, Jillian G.
Etz, Rebecca S.
Vangipuram, Kiran
Barker, Melissa R.
Henry, N. Lynn
Farris, Karen B.
Hertz, Daniel L.
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (KL2TR000434 and 2UL1TR000433)
Michigan Institute for Clinical and Health Research (U050294)
- License Information
-
More Information
Article History
Received: 29 October 2019
Accepted: 16 December 2019
First Online: 2 January 2020
Compliance with ethical standards
:
: Syverson owns stock in Pfizer Inc. and AbbVie Inc. Farris is a consultant and received remuneration from Quio Technologies. Henry received support to her institution for pharma-sponsored clinical trials from Abbvie, Pfizer, and Innocrin Pharmaceuticals. All other authors declare that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the University of Michigan Institutional Review Board (HUM00086259 and HUM00099924) and University of Michigan Rogel Comprehensive Cancer Center (UMCCC 2014.002) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
